SPOTLIGHT: Osteopaths advocate limits on TV drug ads

The American Osteopathic Association says product-specific drug ads should be banned in favor of public-health-style disease education. The osteopaths' resolution, passed at its annual meeting recently, trumps the American Medical Association's call for a study on whether advertising drugs directly to consumers leads to unnecessary prescriptions or increased side effects. Story

Suggested Articles

Reata’s bardoxolone improved kidney function in a phase 3 trial of patients with a rare form of chronic kidney disease.

The suit alleges the FDA imposed the hold “without notice or explanation” and has since “rebuffed” Regenxbio’s repeated requests for an explanation.

Bolt Biotherapeutics presented positive results from animal trials of its lead drug, a tumor-targeting antibody connected to an immune stimulator.